Hypercoagulopathy, acquired coagulation disorders and anticoagulation before, during and after extracorporeal membrane oxygenation in COVID-19: a case series.

Johannes KalbhennHannah GlonneggerMaya WilkeJoachim BansbachBarbara Zieger

Published in: Perfusion (2021)

Coronavirus-induced coagulopathy and bleeding disorders during vvECMO cannot be discriminated via 'routine' coagulation tests. Precise and specific analyses followed by the appropriate treatment of coagulation disorders may help us develop tailored therapeutic concepts to better manage the phases described above.

Keyphrases

extracorporeal membrane oxygenation
sars cov
acute respiratory distress syndrome
atrial fibrillation
coronavirus disease
respiratory failure
venous thromboembolism
high glucose
respiratory syndrome coronavirus
clinical practice
mechanical ventilation
oxidative stress
smoking cessation
stress induced